SG11201809976PA - Protection of plant extracts and compounds from degradation - Google Patents
Protection of plant extracts and compounds from degradationInfo
- Publication number
- SG11201809976PA SG11201809976PA SG11201809976PA SG11201809976PA SG11201809976PA SG 11201809976P A SG11201809976P A SG 11201809976PA SG 11201809976P A SG11201809976P A SG 11201809976PA SG 11201809976P A SG11201809976P A SG 11201809976PA SG 11201809976P A SG11201809976P A SG 11201809976PA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- cannabinoids
- pct
- degradation
- street
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016901758A AU2016901758A0 (en) | 2016-05-11 | Protection of plant extracts and compounds from degradation | |
| PCT/AU2017/050430 WO2017193169A1 (fr) | 2016-05-11 | 2017-05-11 | Protection d'extraits végétaux et de composés contre la dégradation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809976PA true SG11201809976PA (en) | 2018-12-28 |
Family
ID=60266066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809976PA SG11201809976PA (en) | 2016-05-11 | 2017-05-11 | Protection of plant extracts and compounds from degradation |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20190315704A1 (fr) |
| EP (1) | EP3454849A4 (fr) |
| AU (1) | AU2017261847B2 (fr) |
| CA (1) | CA3023767A1 (fr) |
| SG (1) | SG11201809976PA (fr) |
| WO (1) | WO2017193169A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| EP3745884A1 (fr) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Poudre de chanvre |
| US20210315817A1 (en) * | 2018-08-20 | 2021-10-14 | Hexo Operations Inc. | Cannabinoid based self-emulsion systems for infused compositions |
| US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| US11458092B2 (en) | 2018-12-14 | 2022-10-04 | NuVessl, Inc. | Composition with enhanced passenger molecule loading |
| CN110038251B (zh) * | 2019-05-30 | 2021-07-30 | 汉义生物科技(北京)有限公司 | 一种降解大麻素的方法 |
| EP4010024A4 (fr) * | 2019-08-08 | 2023-05-03 | Neptune Wellness Solutions Inc. | Préparations de cannabis pour la voie orale et leurs procédés de fabrication |
| WO2022232574A1 (fr) | 2021-04-29 | 2022-11-03 | Tilray, Inc. | Formulations dans lesquelles le cannabidiol est le constituant dominant, leurs procédés de fabrication et leurs utilisations |
| IT202100014909A1 (it) * | 2021-06-08 | 2022-12-08 | Velleja Res S R L | Formulazioni oleose di cannabinoidi |
| US20230036051A1 (en) * | 2021-07-21 | 2023-02-02 | Resurgent Biosciences, Inc. | Cannabinoid storage stability |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007032962A2 (fr) * | 2005-09-09 | 2007-03-22 | University Of Kentucky | Compositions et procédés destinés à une administration intranasale de cannabidoïdes tricycliques |
| AU2007281918A1 (en) * | 2006-08-04 | 2008-02-14 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
| US8222292B2 (en) * | 2007-08-06 | 2012-07-17 | Insys Therapeutics, Inc. | Liquid cannabinoid formulations |
| WO2009020666A1 (fr) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Formulations liquides à usage oral de cannabinoïdes et procédés de traitement avec celles-ci |
| US9345771B2 (en) * | 2012-10-04 | 2016-05-24 | Insys Development Company, Inc. | Oral cannabinoid formulations |
| CN103110582A (zh) * | 2013-03-04 | 2013-05-22 | 上海医药工业研究院 | 大麻酚类化合物微乳剂及其制备方法 |
-
2017
- 2017-05-11 AU AU2017261847A patent/AU2017261847B2/en not_active Ceased
- 2017-05-11 SG SG11201809976PA patent/SG11201809976PA/en unknown
- 2017-05-11 US US16/300,537 patent/US20190315704A1/en not_active Abandoned
- 2017-05-11 CA CA3023767A patent/CA3023767A1/fr active Pending
- 2017-05-11 WO PCT/AU2017/050430 patent/WO2017193169A1/fr not_active Ceased
- 2017-05-11 EP EP17795190.2A patent/EP3454849A4/fr not_active Withdrawn
-
2022
- 2022-03-15 US US17/695,162 patent/US20220274943A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017261847B2 (en) | 2023-03-30 |
| WO2017193169A1 (fr) | 2017-11-16 |
| CA3023767A1 (fr) | 2017-11-16 |
| EP3454849A4 (fr) | 2019-11-27 |
| AU2017261847A1 (en) | 2018-12-13 |
| US20220274943A1 (en) | 2022-09-01 |
| EP3454849A1 (fr) | 2019-03-20 |
| US20190315704A1 (en) | 2019-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809976PA (en) | Protection of plant extracts and compounds from degradation | |
| SG11201906795SA (en) | Novel plant cells, plants, and seeds | |
| SG11201810116VA (en) | Exosomes comprising therapeutic polypeptides | |
| SG11201811706RA (en) | Process for the preparation of microcapsules | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201809559UA (en) | Substituted pyridines as inhibitors of dnmt1 | |
| SG11201804729RA (en) | Methods and compositions for treating a serpinc1-associated disorder | |
| SG11201408054RA (en) | Pegylated oxm variants | |
| SG11201804368QA (en) | Storage assembly for prosthetic valve | |
| SG11201808682XA (en) | Silicone atoms containing ivacaftor analogues | |
| SG11201810192TA (en) | Antibacterial compositions | |
| SG11201811579VA (en) | Chemiluminescent substrates | |
| SG11201806868TA (en) | Compositions and methods for protecting against airborne pathogens and irritants | |
| SG11201900665VA (en) | Cannabis composition | |
| SG11201407200TA (en) | Liquid formulation | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201903427UA (en) | Deodorizing agent comprising zinc neodecanoate | |
| SG11201809537VA (en) | Urea motif containing compounds and derivatives thereof as antibacterial drugs | |
| SG11201908114UA (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
| SG11201810516UA (en) | Combinations comprising histone deacetylase inhibitors | |
| SG11201811093RA (en) | Antimicrobial compounds and methods for use thereof | |
| SG11201806480UA (en) | Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer | |
| SG11201807404XA (en) | Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease | |
| SG11201805423TA (en) | Indolinones compounds and their use in the treatment of fibrotic diseases | |
| SG11201408509PA (en) | Racecadotril lipid compositions |